Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2020

01-04-2020 | Care | Original Paper

Recent Incarceration as a Primary Barrier to Virologic Suppression Among Women Living with HIV: Results from a Longitudinal Community-Based Cohort in a Canadian Setting

Authors: Margaret Erickson, Neora Pick, Flo Ranville, Melissa Braschel, Mary Kestler, Karen Kinvig, Andrea Krüsi, Kate Shannon, SHAWNA Project

Published in: AIDS and Behavior | Issue 4/2020

Login to get access

Abstract

Women living with HIV (WLWH) are disproportionately represented among incarcerated populations yet there is a paucity of research on how incarceration shapes HIV treatment outcomes for women. Data is drawn from SHAWNA (Sexual health and HIV/AIDS: Women’s Longitudinal Needs Assessment), a longitudinal community-based open research cohort with cis and trans WLWH in Metro Vancouver, Canada (2010–2017). Multivariable logistic regression using generalized estimating equations (GEE) longitudinally modeled the effect of incarceration on virologic suppression (HIV plasma VL < 50 copies/mL), adjusting for potential confounders. Amongst 292 WLWH, the majority (74%) had been incarcerated in their lifetime and 17% were incarcerated over the study period. Exposure to recent incarceration was independently correlated with reduced odds of virologic suppression (AOR: 0.42, 95% CI 0.22–0.80). This study suggests critical need for research and interventions to better address factors shaping ART adherence and retention in care for WLWH, both within correctional centres and following release from prison.
Literature
1.
2.
Rubenstein LS, Amon JJ, McLemore M, Eba P, Dolan K, Lines R, et al. HIV, prisoners, and human rights. Lancet. 2016;388(10050):1202–14.CrossRefPubMed
3.
Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care. 2016;29:1–9.
4.
Dolan K, Kite B, Black E, Aceijas C, Stimson GV. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7(1):32–41.CrossRefPubMed
5.
Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, et al. HIV and tuberculosis in prisons in sub-Saharan Africa. Lancet. 2016;388(10050):1215–27.CrossRefPubMedPubMedCentral
6.
UNAIDS. The Gap Report 2014. Joint United Nations programme on HIV/AIDS. Geneva; 2014.
7.
United Nations Office on Drugs and Crime; Joint United Nations Programme on HIV/AIDS; The World Bank. HIV and Prisons in sub-Saharan Africa: opportunities for action. Vienna; 2007.
8.
United Nations office on drugs and crime; Joint United Nations Programme on HIV/AIDS. Women and HIV in prison settings. Austria; 2008.
9.
Beyrer C, Kamarulzaman A, McKee M. Prisoners, prisons, and HIV: time for reform. Lancet. 2016;388(10049):1033–5.CrossRefPubMed
10.
The Correctional Investigator Canada. Office of the correctional investigator annual report 2014–2015. 2015.
11.
Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Can Med Assoc J. 2007;177(3):252–6.CrossRef
12.
Carter A, Eun Min J, Chau W, Lima VD, Kestler M, Pick N, et al. Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000–2010). Sluis-Cremer N, editor. PLoS ONE. 2014;9(3):92334.CrossRef
13.
Hogg RS, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Rates of disease progression by baseline CD4 Cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286(20):2568.CrossRefPubMed
14.
Lichtenstein B. Domestic violence in barriers to health care for HIV-positive women. AIDS Patient Care STDs. 2006;20(2):122–32.CrossRefPubMed
15.
Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091–100.CrossRefPubMed
16.
Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248–57.CrossRefPubMedPubMedCentral
17.
Logie CH, James LL, Tharao W, Loutfy MR. HIV, gender, race, sexual orientation, and sex work a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario. Daniels K, editor. PLoS Med. 2011;8(11):e1001124.CrossRefPubMedPubMedCentral
18.
Aziz M, Smith KY. Challenges and successes in linking HIV-infected women to care in the united states. Clin Infect Dis. 2011;52(SUPPL. 2):231–7.CrossRef
19.
Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefPubMedPubMedCentral
20.
Spaulding AC, Messina LC, Kim BI, Chung K-W, Lincoln T, Teixeira P, et al. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav. 2013;17(S2):203–11.CrossRef
21.
Zelenev A, Marcus R, Kopelev A, Cruzado-Quinones J, Spaulding A, Desabrais M, et al. Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav. 2013;17(Suppl 2):181–94.CrossRef
22.
Booker CA, Flygare CT, Solomon L, Ball SW, Pustell MR, Bazerman LB, et al. Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav. 2013;17(SUPPL. 2):128–36.CrossRef
23.
Springer SA, Altice FL, Brown SE, Di Paola A. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015;157:158–65.CrossRefPubMedPubMedCentral
24.
Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS ONE. 2012;7(5):e38335.CrossRefPubMedPubMedCentral
25.
Wang EA, McGinnis KA, Long JB, Akgün KM, Edelman EJ, Rimland D, et al. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict. 2015;24(2):178–84.CrossRefPubMedPubMedCentral
26.
Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.CrossRefPubMedPubMedCentral
27.
Althoff AL, Zelenev A, Meyer JP, Fu J, Brown S-E, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):156–70.CrossRefPubMedCentral
28.
Teixeira PA, Jordan AO, Zaller N, Shah D, Venters H. Health outcomes for HIV-infected persons released from the New York city jail system with a transitional care-coordination plan. Am J Public Health. 2015;105(2):351–7.CrossRefPubMedPubMedCentral
29.
Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104(3):434–41.CrossRefPubMedPubMedCentral
30.
Beckwith C, Castonguay BU, Trezza C, Bazerman L, Patrick R, Cates A, et al. Gender differences in HIV care among criminal justice-involved persons: baseline data from the CARE+ correction study. PLoS ONE. 2017;12(1):1–15.CrossRef
31.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.CrossRefPubMedPubMedCentral
32.
Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.CrossRefPubMed
33.
Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–36.CrossRefPubMed
34.
Kennedy MC, Kerr T, Mcneil R, Parashar S, Montaner J, Wood E, et al. Residential eviction and risk of detectable plasma HIV-1 RNA viral load among HIV-positive people who use drugs. AIDS Behav. 2017;21(3):678–87.CrossRefPubMedPubMedCentral
35.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefPubMed
36.
Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290.CrossRef
37.
Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9.CrossRefPubMed
38.
Montaner JSG, Lima VD, Harrigan PR, Lourenço L, Yip B, Nosyk B, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. Sluis-Cremer N, editor. PLoS ONE. 2014;9(2):e87872.CrossRefPubMedPubMedCentral
39.
Public Health Agency of Canada. Summary: Estimates of HIV Incidence, Prevalence and proportion undiagnosed in Canada, 2014. 2015.
40.
Correctional Service of Canada. Summary of Emerging Findings from the 2007 National Inmate Infectious Diseases and Risk-Behaviours Survey. 2010.
41.
Public Health Agency of Canada. HIV and AIDS in Canada: Surveillance Report to December 31, 2013. 2014.
42.
Statistics Canada. Aboriginal peoples in Canada: first nations people. Census Program: Metis and Inuit; 2011.
43.
Avery AK, Ciomcia RW, Lincoln T, Desbrais M, Jordan AO, Rana AI, et al. Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study. AIDS Behav. 2013;17(S2):137–44.CrossRef
44.
Goldenberg SM, Montaner J, Duff P, Nguyen P, Dobrer S, Guillemi S, et al. Structural barriers to antiretroviral therapy among sex workers living with HIV: findings of a longitudinal study in Vancouver. Can AIDS Behav. 2016;20(5):977–86.CrossRefPubMed
45.
Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRefPubMedPubMedCentral
46.
Lin S, Martin R, Milloy M, Carter A, Patterson S, Webster K, et al. Factors associated with ever and recent incarceration experience among women living with HIV in Canada. AIDS 2016, Abstr Number THPED307. 2016;.
47.
Roberson DW, White BL, Fogel CI. Factors influencing adherence to antiretroviral therapy for HIV-infected female inmates. J Assoc Nurses AIDS Care. 2009;20(1):50–61.CrossRefPubMedPubMedCentral
48.
49.
Belenko S, Dembo R, Copenhaver M, Hiller M, Swan H, Albizu Garcia C, et al. HIV stigma in prisons and jails: results from a staff survey. AIDS Behav. 2016;20(1):71–84.CrossRefPubMedPubMedCentral
50.
Ministry of Public Safety and Solicitor General BC. A Profile of BC corrections: reduce reoffending, protect communities (2017). 2017.
51.
Pick N, Kinvig K, Quaia C, Paquette T, Slater A, Kestler M, et al. Bridging the Gap : an Oak Tree Clinic interdisciplinary outreach Approach to HIV care at alouette correctional centre for women in British Columbia. In: 4th International Workshop on HIV & Women. Washington, DC; 2014.
52.
Pai NP, Estes M, Moodie EEM, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS ONE. 2009;4(9):e7115.CrossRefPubMed
53.
Lincoln T, Kennedy S, Tuthill R, Roberts C, Conklin TJ, Hammett TM. Facilitators and barriers to continuing healthcare after jail: a community-integrated program. J Ambul Care Manage. 2006;29(1):2–16.CrossRefPubMed
54.
Martin R, Buxton J, Smith M, Hislop G. The scope of the problem: the health of incarcerated women in BC. BC Med J. 2012;54(10):502.
55.
Duff P, Goldenberg S, Deering K, Montaner J, Nguyen P, Dobrer S, et al. Barriers to viral suppression among female sex workers. JAIDS J Acquir Immune Defic Syndr. 2016;73(1):83–90.CrossRefPubMed
56.
Fu JJ, Herme M, Wickersham JA, Zelenev A, Althoff A, Zaller ND, et al. Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav. 2013;17(Suppl 2):145–55.CrossRef
57.
Espino SR, Fletcher J, Gonzalez M, Precht A, Xavier J, Matoff-Stepp S. Violence screening and viral load suppression among HIV-positive women of color. AIDS Patient Care STDS. 2015;29(S1):S36–41.CrossRefPubMedPubMedCentral
58.
Donastorg Y, Barrington C, Perez M, Kerrigan D, Baral S, Beyrer C, et al. Abriendo Puertas baseline findings from an integrated intervention to promote prevention, treatment and care among FSW Living with HIV in the dominican republic. Tang JW, editor. PLoS ONE. 2014;9(2):88157.CrossRef
59.
Hatcher AM, Smout EM, Turan JM, Christofides N, Stöckl H. Intimate partner violence and engagement in HIV care and treatment among women. AIDS. 2015;29(16):2183–94.CrossRefPubMed
60.
Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav. 2012;16(8):2160–70.CrossRefPubMed
61.
Natukunda J, Kirabira P, Ing K, Ong C, Shibanuma A, Jimba M. Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study. Trop Med Health. 2019;47:8.CrossRefPubMedPubMedCentral
62.
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11(2):167–74.CrossRefPubMedPubMedCentral
Metadata
Title
Recent Incarceration as a Primary Barrier to Virologic Suppression Among Women Living with HIV: Results from a Longitudinal Community-Based Cohort in a Canadian Setting
Authors
Margaret Erickson
Neora Pick
Flo Ranville
Melissa Braschel
Mary Kestler
Karen Kinvig
Andrea Krüsi
Kate Shannon
SHAWNA Project
Publication date
01-04-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02606-5

Other articles of this Issue 4/2020

AIDS and Behavior 4/2020 Go to the issue

Original Paper

Disparities in Retention in Care Among Adults Living with HIV/AIDS: A Systematic Review

Original Paper

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)

Original Paper

How Do Treatment Priorities Differ Between Patients in HIV Care and Their Providers? A Mixed-Methods Study

Original Paper

Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV

Original Paper

Impact of an HIV Care Coordination Program on the Timeliness of Viral Suppression and Immune Recovery Among Clients Newly Diagnosed with HIV

Original Paper

Association of HIV Infection with Epilepsy and Other Comorbid Conditions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits